Life Science real estate transaction volume picked up at the end of 2023, according to newly released data from www.revistalab.com. A total of $3.2 billion (B) worth of life science real estate was traded in the quarter. This marks the highest quarter for transaction activity since 3Q22 when $3.4B traded hands. Trailing twelve month (TTM) volume also picked up in the 4th quarter of 2023. TTM volume was $6.4B in the quarter which was up from $4.8B in 3Q23 but still down from 4Q22’s observation of $13.3B. We will see if this portends a trend of increasing transaction volume in 2024 but nonetheless, an uptick in transaction volume is a welcome sight for many stakeholders in the sector. For more detail on the trades that make up these transactions, leverage the www.revistalab transactions database. Please contact Hilda Martin for more information.
